Do Glycine-Extended Hormone Precursors have Clinical Significance?

References

• Du Vigneaud V , ResslerC, TrippettS. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J. Biol. Chem.205, 949–957 (1953).
   PubMed Web of Science ®Google Scholar
• Acher R , ChauvetJ. La structure de la vasopressine de boeuf. Biochem. Biophys. Acta12, 487–488 (1953).
   PubMedGoogle Scholar
• Gregory H , HardyPM, JonesDS, KennerGW, SheppardRC. The antral hormone gastrin: structure of gastrin. Nature204, 931–933 (1964).
   PubMed Web of Science ®Google Scholar
• Handbook of Biologically Active Peptides (2nd Edition). KastinAJ ( Ed.). Elsevier Academic Press, Amsterdam, 1–1911 (2013).
   Google Scholar
• Tatemoto K , MuttV. Chemical determination of polypeptide hormones. Proc. Natl Acad. Sci. USA75, 4115–4119 (1978).
   PubMed Web of Science ®Google Scholar
• Tatemoto K , MuttV. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature285, 417–418 (1980).
   PubMed Web of Science ®Google Scholar
• Vivoli M , LindbergI. Prohormone convertase 1/3. In: Handbook of Biologically Active Peptides.KastinAJ ( Ed.) Elsevier Academic Press, Amsterdam, 1789–1796 (2013).
   Google Scholar
• Vivoli M , LindbergI. Prohormone convertase 2. In: Handbook of Biologically Active Peptides.KastinAJ ( Ed.) Elsevier Academic Press, Amsterdam, 1797–1802 (2013).
   Google Scholar
• Fricker LD . Carboxypeptidases E and D. In: Handbook of Biologically Active Peptides.KastinAJ ( Ed.) Elsevier Academic Press, Amsterdam, 1715–1720 (2013).
   Google Scholar
• Eipper BA , MilgramSL, HustenEJ, YunHY, MainsRE. Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing, and routing domains. Protein Sci.2, 489–497 (1993).
   PubMed Web of Science ®Google Scholar
• Vishwanatha KS , MainsRE, EipperBA. Peptidylglycine amidating monooxygenase (PAM). In: Handbook of Biologically Active Peptides.KastinAJ ( Ed.) Elsevier Academic Press, Amsterdam, 1780–1788 (2013).
   Google Scholar
• Yin P , Bousquet-MooreD, AnnangudiSPet al. Probing the production of amidated peptides following genetic and dietary copper manipulations. PLoS One6, e286792011 (2011).
   Web of Science ®Google Scholar
• Kline CD , MayfieldM, BlackburnNJ. HHM motif at the CuH-site of peptidylglycine monooxygenase is a pH-dependent conformational switch. Biochemistry52, 2586–2596 (2013).
   PubMed Web of Science ®Google Scholar
• Hilsted L , RehfeldJF, SchwartzTW. Impaired alpha-carboxyamidation of gastrin in vitamin C-deficient guinea pigs. FEBS Lett.196, 151–154 (1986).
   PubMed Web of Science ®Google Scholar
• Sugano K , AponteGW, YamadaT. Identification and characterization of glycine-extended post-translational processing intermediates of progastrin in porcine stomach. J. Biol. Chem.260, 11724–11729 (1985).
   PubMed Web of Science ®Google Scholar
• Hilsted L , RehfeldJF. Alpha-carboxyamidation of antral progastrin. Relation to other post-translational modifications. J. Biol. Chem.262, 16953–16957 (1987).
   PubMed Web of Science ®Google Scholar
• Sugano K , ParkJ, DobbinsWO, YamadaT. Glycine-extended progastrin processing intermediates: accumulation and cosecretion with gastrin. Am. J. Physiol.253, G502–G507 (1987).
   PubMedGoogle Scholar
• Del Valle J , SuganoK, YamadaT. Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues. Gastroenterology92, 1908–1912 (1987).
   PubMed Web of Science ®Google Scholar
• Hilsted L , BardramL, RehfeldJF. Progastrin maturation during ontogenesis. Accumulation of glycine-extended gastrins in rat antrum at weaning. Biochem. J.255, 397–402 (1988).
   PubMed Web of Science ®Google Scholar
• Marino LR , SuganoK, YamadaT. Development of gastrin synthesis and posttranslational processing mechanisms in rats. Am. J. Physiol.254, G87–G92 (1988).
   PubMedGoogle Scholar
• Azuma T . Secretion and biosynthesis of COOH-terminal glycine-extended progastrin (gastrin-G) in rat gastric antrum. Gastroenterol. Jpn22, 149–157 (1987).
   PubMedGoogle Scholar
• Seva C , DickinsonCJ, YamadaT. Growth-promoting effects of glycine-extended progastrin. Science265, 410–412 (1994).
   PubMed Web of Science ®Google Scholar
• Eipper BA , ParkL, KeutmannHT, MainsRE. Amidation of joining peptide, a major pro-ACTH/endorphin-derived product peptide. J. Biol. Chem.261, 8686–8694 (1986).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , BundgaardJR, HannibalJet al. The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6. Endocrinology149, 1600–1608 (2008).
   PubMed Web of Science ®Google Scholar
• Kelly RB . Pathways of protein secretion in eukaryotes. Science230, 25–32 (1985).
   PubMed Web of Science ®Google Scholar
• Kögel T , GerdesHH. Maturation of secretory granules. Results Probl. Cell Differ.50, 1–20 (2010).
   PubMedGoogle Scholar
• Bundgaard JR , BirkedalH, RehfeldJF. Progastrin is directed to the regulated secretory pathway by synergistically acting basic and acidic motifs. J. Biol. Chem.279, 5488–5493 (2004).
   PubMed Web of Science ®Google Scholar
• Bundgaard JR , RehfeldJF. Distinct linkage between post-translational processing and differential secretion of progastrin derivatives in endocrine cells. J. Biol. Chem.283, 4014–4021 (2008).
   PubMed Web of Science ®Google Scholar
• Hilsted L , HansenCP. Corelease of amidated and glycine-extended antral gastrins after a meal. Am. J. Physiol.255, G665–G669 (1988).
   PubMedGoogle Scholar
• Rehfeld JF , StadilF. Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. Gut14, 369–373 (1973).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , GingrasMH, BardramL, HilstedL, GoetzeJP, PoitrasP. The Zollinger–Ellison syndrome and mismeasurement of gastrin. Gastroenterology140, 1444–1453 (2011).
   PubMed Web of Science ®Google Scholar
• van Solinge WW , NielsenFC, Friis-HansenL, FalkmerUG, RehfeldJF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology104, 1099–1107 (1993).
   PubMed Web of Science ®Google Scholar
• Kochman ML , DelValleJ, DickinsonCJ, BolandCR. Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem. Biophys. Res. Commun.189, 1165–1169 (1992).
   PubMed Web of Science ®Google Scholar
• Singh P , XuZ, DaiB, RajaramanS, RubinN, DhruvaB. Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. Am. J. Physiol.266, G459–G468 (1994).
   PubMed Web of Science ®Google Scholar
• Siddheshwar RK , GrayJC, KellySB. Plasma levels of progastrin but not amidated gastrin or glycine-extended gastrin are elevated in patients with colorectal carcinoma. Gut48, 47–52 (2001).
   PubMed Web of Science ®Google Scholar
• Ciccotosto GD , McLeishA, HardyKJ, ShulkesA. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology109, 1142–1153 (1995).
   PubMed Web of Science ®Google Scholar
• van Solinge WW , OdumL, RehfeldJF. Ovarian cancers express and process progastrin. Cancer Res.53, 1823–1828 (1993).
   PubMed Web of Science ®Google Scholar
• Jensen S , BorchK, HilstedL, RehfeldJF. Progastrin processing during antral G-cell hypersecretion in humans. Gastroenterology96, 1063–1070 (1989).
   PubMed Web of Science ®Google Scholar
• Hilsted L , RehfeldJF. Measurement of precursors for alpha-amidated hormones by radioimmunoassay of glycine-extended peptides after trypsin-carboxypeptidase B cleavage. Anal. Biochem.152, 119–126 (1986).
   PubMed Web of Science ®Google Scholar
• Fahrenkrug J , OttesenB, PalleC. Non-amidated forms of VIP (glycine-extended VIP and VIP-free acid) have full bioactivity on smooth muscle. Regul. Pept.26, 235–239 (1989).
   PubMedGoogle Scholar
• Fahrenkrug J . Glycine-extended processing intermediate of proVIP: a new form of VIP in the rat. Biochem. Biophys. Res. Commun.178, 173–177 (1991).
   PubMed Web of Science ®Google Scholar
• Todisco A , TakeuchiY, SevaC, DickinsonCJ, YamadaT. Gastrin and glycine-extended progastrin processing intermediates induce different programs of early gene activation. J. Biol. Chem.270, 28337–28341 (1995).
   PubMed Web of Science ®Google Scholar
• Koh TJ , FieldJK, VarroAet al. Glycine-extended gastrin promotes the growth of lung cancer. Cancer Res.64, 196–201 (2004).
   PubMed Web of Science ®Google Scholar
• Patel O , DumesnyC, GiraudAS, BaldwinGS, ShulkesA. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor. Biochem. Pharmacol.68, 2129–2142 (2004).
   PubMed Web of Science ®Google Scholar
• Beales IL , OgunwobiO. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways. Mol. Cell. Endocrinol.247, 140–149 (2006).
   PubMed Web of Science ®Google Scholar
• Ferrand A , Kowalski-ChauvelA, PannequinJet al. Glycine-extended gastrin activates two independent tyrosine-kinases in upstream of p85/p110 phosphatidylinositol 3-kinase in human colonic tumour cells. World J. Gastroenterol.12, 1859–1864 (2006).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , BardramL, HilstedL. Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin. Cancer Res.49, 2840–2843 (1989).
   PubMed Web of Science ®Google Scholar
• Caplin M , KhanK, SavageKet al. Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma. J. Hepatol.30, 519–526 (1999).
   PubMed Web of Science ®Google Scholar
• Goetze JP , NielsenFC, BurcharthF, RehfeldJF. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma. Cancer88, 2487–2494 (2000).
   PubMed Web of Science ®Google Scholar
• Goetze JP , EilandS, SvendsenLB, VainerB, HannibalJ, RehfeldJF. Characterization of gastrins and their receptor in solid human gastric adenocarcinomas. Scand. J. Gastroenterol.48, 688–695 (2013).
   PubMed Web of Science ®Google Scholar
• Abdalla SI , Lao-SirieixP, NovelliMR, LovatLB, SandersonR, FitzgeraldRC. Gastrin-induced cyclooxygenase-2 expression in Barrett’s carcinogenesis. Clin. Cancer Res.10, 4784–4792 (2004).
   PubMed Web of Science ®Google Scholar
• Wang JS , VarroA, LightdaleCJet al. Elevated serum gastrin is associated with a history of advanced neoplasia in Barret’s esophagus. Am. J. Gastroenterol.41, 1039–1045 (2010).
   Google Scholar
• Beales ILP , OgunwobiOO. Glycine-extended gastrin stimulates proliferation via JAK2- and Akt-dependent NF-kB activation in Barret’s oesophageal adenocarcinoma cells. Med. Cell. Endocrinol.296, 94–102 (2008).
   PubMed Web of Science ®Google Scholar
• Beales ILP , OgunwobiOO. Glycine-extended gastrin inhibits apoptosis in Barret’s oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation. J. Mol. Endocrinol.42, 305–318 (2009).
   PubMed Web of Science ®Google Scholar
• Singh P , WuH, ClarkC, OwliaA. Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogeneous gastrins on colon cancer and intestinal epithelial cells. Oncogene26, 425–440 (2007).
   PubMed Web of Science ®Google Scholar
• Kowalski-Chauvel A , NajibS, TikhonovaIGet al. Identification of the F1-ATPase at the cell surface of colonic epithelial cells. J. Biol. Chem.287, 41458–41468 (2012).
   PubMed Web of Science ®Google Scholar
• Iwasaki H , HirataY, IwashinaM, SatoK, MarumoF. Specific binding sites for proadrenomedullin N-terminal peptide (PAMP) in the rat. Endocrinology137, 3045–3050 (1996).
   PubMed Web of Science ®Google Scholar
• Kitamura K , KatoJ, KawamotoMet al. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem. Biophys. Res. Commun.244, 551–555 (1998).
   PubMed Web of Science ®Google Scholar
• Cao YN , KitamuraK, ItoKet al. Glycine-extended adrenomedullin exerts vasodilator effect through amidation in the rat aorta. Regul. Pept.113, 109–114 (2003).
   PubMedGoogle Scholar
• Smith KA , PatelO, LachalSet al. Production, secretion and biological activity of the C-terminal flanking peptide of human progastrin. Gastroenterology131, 1463–1474 (2006).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF . Prohormonal junk fragments as hormones?Gastroenterology131, 1638–1640 (2006).
   PubMed Web of Science ®Google Scholar
• Do C , BertrandC, PalasseJet al. A new biomarker that predicts colonic neoplasia outcome in patients with hyperplastic colonic polyps. Cancer Prev. Res.5, 675–684 (2012).
   PubMed Web of Science ®Google Scholar
• Watson SA , MichaeliD, GrimesSet al. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res.56, 880–885 (1996).
   PubMed Web of Science ®Google Scholar
• Watson SA , MorrisTM, VarroA, MichaeliD, SmithAM. A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth. Gut45, 812–817 (1999).
   PubMed Web of Science ®Google Scholar
• Bardram L , RehfeldJF. Production and evaluation of monospecific antibodies for a processing-independent sequence of human progastrin. Scand. J. Clin. Lab. Invest.49, 173–182 (1989).
   PubMed Web of Science ®Google Scholar
• Makishimi R , LarkinP, MichaeliD, GaginellaTS. Active immunization against gastrin-17 with an N-terminal derived immunogen inhibits gastric and duodenal lesions in rats. Gatroenterology104, A824 (1994).
   Google Scholar
• Watson SA , MichaeliD, GrimesSet al. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res.56, 880–885 (1996).
   PubMed Web of Science ®Google Scholar
• Gilliam AD , BroomeP, TopuzovEGet al. An international multicenter randomized controlled trial of G17DT in patients with pancreatic cancer. Pancreas41, 374–379 (2012).
   PubMed Web of Science ®Google Scholar
• Aphton Corporation . Gastrin 17 vaccine – Aphton: anti-gastrin 17 immunogen, G17DT. BioDrugs17, 223–225 (2003).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , GoetzeJP. Gastrin vaccination against gastrointestinal and pancreatic cancer. Scand. J. Gastroenterol.41, 122–123 (2006).
   PubMed Web of Science ®Google Scholar
• Hilsted L , HintK, ChristiansenJ, RehfeldJF. Neither glycine-extended gastrin nor the 1–13 fragment of gastrin-17 influences gastric acid secretion in humans. Gastroenterology94, 96–102 (1988).
   PubMed Web of Science ®Google Scholar
• Palnaes Hansen C , StadilF, RehfeldJF. Metabolism and influence of glycine-extended gastrin on gastric acid secretion in man. Digestion57, 22–29 (1996).
   PubMed Web of Science ®Google Scholar
• Cui GL , SandvikAK, MunkvoldB, WaldumHL. Glycine-extended gastrin-17 stimulates acid secretion only via CCK-2 receptor-induced histamine release in the totally isolated vascularly perfused rat stomach. Acta Physiol. Scand.174, 125–130 (2002).
   PubMedGoogle Scholar
• Rehfeld JF , BardramL, HilstedL, GoetzeJP. An evaluation of chromogranin A versus gastrin and progastrin in gastrinoma diagnosis and control. Biomark. Med.8(4), 571–580 (2014).
   PubMed Web of Science ®Google Scholar